← Leaderboards
David Feldser
University Of Pennsylvania
$8,736,307
Attributed
$9,720,795
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,720,795 · 8
By mechanism
R01$8,395,637 · 5
R00$707,037 · 1
R21$384,921 · 1
K99$233,200 · 1
Top collaborators
- Marcelo Gabriel Kazanietz3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Marcelo Gabriel Kazanietz$22,841,058
- Charles V Clevenger$7,683,047
- Alexander Ploss$13,732,497
- Kathryn E Saatman$6,656,271
- Joseph G Sodroski$53,351,794
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTumorMalignant NeoplasmsCellsGene ExpressionIn VivoProgramsPathway InteractionsGenesMouse ModelNeoplastic CellMediatingTumor Suppressor ProteinsMalignant Neoplasm Of LungSignal TransductionRestorationTumor SuppressionMutationInsightGenetically Engineered MouseCancer CellInnovationLung AdenocarcinomaGene Function
Grant awards (28)
Protein kinase C and lung carcinogenesis$653,908
R01 · FY2025 · CA
Context dependent tumor suppression$454,922
R01 · FY2025 · CA · contact PI
Identifying the Impact of SETD2 Inactivation in Lung Adenocarcinoma$434,444
R01 · FY2025 · CA · contact PI
Protein kinase C and lung carcinogenesis$640,695
R01 · FY2024 · CA
Context dependent tumor suppression$454,922
R01 · FY2024 · CA · contact PI
Identifying the Impact of SETD2 Inactivation in Lung Adenocarcinoma$410,628
R01 · FY2024 · CA · contact PI
Protein kinase C and lung carcinogenesis$674,373
R01 · FY2023 · CA
Identifying the Impact of SETD2 Inactivation in Lung Adenocarcinoma$439,136
R01 · FY2023 · CA · contact PI
Identifying the Impact of SETD2 Inactivation in Lung Adenocarcinoma$445,882
R01 · FY2022 · CA · contact PI
Deconstructing the multi-faceted roles of Rb in tumor progression$360,922
R01 · FY2022 · CA · contact PI
Deconstructing the multi-faceted roles of Rb in tumor progression$368,288
R01 · FY2021 · CA · contact PI
Deconstructing the multi-faceted roles of Rb in tumor progression$368,288
R01 · FY2020 · CA · contact PI
Deconstructing the multi-faceted roles of Rb in tumor progression$357,238
R01 · FY2019 · CA · contact PI
p53-Mediated Tumor Immune Surveillance$355,019
R01 · FY2019 · CA · contact PI
p53-Mediated Tumor Immune Surveillance$71,240
R01 · FY2019 · CA · contact PI
Deconstructing the multi-faceted roles of Rb in tumor progression$368,288
R01 · FY2018 · CA · contact PI
p53-Mediated Tumor Immune Surveillance$366,000
R01 · FY2018 · CA · contact PI
p53-Mediated Tumor Immune Surveillance$73,444
R01 · FY2018 · CA · contact PI
p53-Mediated Tumor Immune Surveillance$366,000
R01 · FY2017 · CA · contact PI
Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer$210,105
R21 · FY2017 · CA · contact PI
p53-Mediated Tumor Immune Surveillance$366,000
R01 · FY2016 · CA · contact PI
Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer$174,816
R21 · FY2016 · CA · contact PI
p53-Mediated Tumor Immune Surveillance$366,000
R01 · FY2015 · CA · contact PI
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression$236,784
R00 · FY2015 · CA · contact PI
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression$236,194
R00 · FY2014 · CA · contact PI
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression$234,059
R00 · FY2013 · CA · contact PI
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression$116,600
K99 · FY2012 · CA · contact PI
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppression$116,600
K99 · FY2011 · CA · contact PI